Page last updated: 2024-11-04

sulforaphane and Intraepithelial Prostatic Neoplasia

sulforaphane has been researched along with Intraepithelial Prostatic Neoplasia in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research Excerpts

ExcerptRelevanceReference
" We have shown previously that oral administration of sulforaphane (SFN) significantly inhibits the incidence and/or burden of prostatic intraepithelial neoplasia and well-differentiated adenocarcinoma in TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice."3.88Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. ( Hahm, ER; Jacobs, BL; Kim, SH; Pore, SK; Singh, KB; Singh, SV, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, KB1
Kim, SH1
Hahm, ER1
Pore, SK1
Jacobs, BL1
Singh, SV1

Other Studies

1 other study available for sulforaphane and Intraepithelial Prostatic Neoplasia

ArticleYear
Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
    Carcinogenesis, 2018, 05-28, Volume: 39, Issue:6

    Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Chemoprevention; Fatty Acid Synthases; Fatty Acids

2018